Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATBRAD: Early Intensive Medical Therapy for Branch Atheromatous Disease
NCT04824911Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2021
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clopidogrel, aspirin, atorvastatin, rosuvastatin in branch atheromatous disease (BAD), sponsored by Chang Gung Memorial Hospital. Started Mar 2021; status: completed.
02
Drugs
clopidogrelaspirinatorvastatinrosuvastatin
03
Conditions
branch atheromatous disease (BAD)
Beyond the preview
Go deeper on NCT04824911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04824911.